181 related articles for article (PubMed ID: 34975754)
1. Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer.
Yang X; Li X; Dong Y; Fan Y; Cheng Y; Zhai L; Zhang S; Zhou J; Wang J
Front Endocrinol (Lausanne); 2021; 12():780769. PubMed ID: 34975754
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.
Feng X; Li XC; Yang X; Cheng Y; Dong YY; Wang JY; Zhou JY; Wang JL
BMC Cancer; 2023 Jul; 23(1):622. PubMed ID: 37403054
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients.
Li X; Yang X; Cheng Y; Dong Y; Wang J; Wang J
J Gynecol Oncol; 2023 Nov; 34(6):e69. PubMed ID: 37293802
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic factors, and two nomograms for endometrial cancer patients with bone metastasis: A large cohort retrospective study.
Yang F; Zhao R; Huang X; Wang Y
Medicine (Baltimore); 2021 Sep; 100(36):e27185. PubMed ID: 34516519
[TBL] [Abstract][Full Text] [Related]
5. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
[TBL] [Abstract][Full Text] [Related]
6. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics.
Liwei L; He L; Yibo D; Luyang Z; Zhihui S; Nan K; Danhua S; Junzhu W; Zhiqi W; Jianliu W
World J Surg Oncol; 2023 Oct; 21(1):332. PubMed ID: 37865800
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
8. Metabolic Syndrome in Endometrial Cancer Patients: Systematic Review.
Adambekov S; Yi Y; Fabio A; Miljkovic I; Edwards RP; Lopa S; Linkov F
Metab Syndr Relat Disord; 2019 Jun; 17(5):241-249. PubMed ID: 30932741
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study.
Li Y; Hou X; Chen W; Wang S; Ma X
Sci Rep; 2023 Nov; 13(1):20270. PubMed ID: 37985680
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram Based on Metabolic Risk Score for Assessing Lymphovascular Space Invasion in Patients with Endometrial Cancer.
Wang J; Li X; Yang X; Wang J
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497730
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
13. A nomogram for predicting overall survival in patients with type II endometrial carcinoma: a retrospective analysis and multicenter validation study.
Ren X; Wang MM; Wang G; Sun XM; Xia TT; Yao Y; Wang CC; Jiang AF; Wang H; Cao J; Wei YJ; Sun CG
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):233-247. PubMed ID: 36647873
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.
Ni J; Zhu T; Zhao L; Che F; Chen Y; Shou H; Yu A
Clin Transl Oncol; 2015 Oct; 17(10):835-9. PubMed ID: 26260911
[TBL] [Abstract][Full Text] [Related]
15. The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort.
Huss A; Ihorst G; Timme-Bronsert S; Hasenburg A; Oehler MK; Klar M
Ann Surg Oncol; 2018 Dec; 25(13):3966-3973. PubMed ID: 30238246
[TBL] [Abstract][Full Text] [Related]
16. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer.
Feldman A; Chaugle S; Burmeister C; Munkarah A; Elshaikh MA
Gynecol Obstet Invest; 2019; 84(3):283-289. PubMed ID: 30540995
[TBL] [Abstract][Full Text] [Related]
17. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
18. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
19. A nomogram prediction model for lymph node metastasis in endometrial cancer patients.
Wang Z; Zhang S; Ma Y; Li W; Tian J; Liu T
BMC Cancer; 2021 Jun; 21(1):748. PubMed ID: 34187416
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
